| OR | 95% CI | P value | OR | 95% CI | P value |
---|---|---|---|---|---|---|
SIRI | 1.160 | 1.103–1.221 | < 0.001 | 1.782 | 1.675–1.906 | 0.001 |
Age, years | 1.072 | 1.041–1.103 | < 0.001 |  |  |  |
Male | 0.546 | 0.282–1.056 | 0.072 |  |  |  |
BMI, kg/m2 | 1.171 | 0.999–1.373 | 0.052 |  |  |  |
Killip class ≥ 2 | 4.782 | 2.591–8.826 | < 0.001 |  |  |  |
Hypertension | 1.686 | 0.916–3.106 | 0.093 |  |  |  |
Diabetes mellitus | 2.421 | 1.275–4.594 | 0.007 |  |  |  |
Smoking | 0.699 | 0.384–1.272 | 0.241 |  |  |  |
Alcohol consumption | 1.264 | 0.673–2.373 | 0.466 |  |  |  |
Cardiogenic shock | 3.833 | 1.966–7.473 | < 0.001 |  |  |  |
Biochemical indicators | ||||||
White blood cells, 109/L | 1.165 | 1.085–1.251 | < 0.001 |  |  |  |
Hemoglobin (g/l) | 0.977 | 0.959–0.995 | 0.011 |  |  |  |
Lymphocyte (109/l) | 0.190 | 0.094–0.382 | < 0.001 |  |  |  |
Neutrophil (109/l) | 1.120 | 1.048–1.197 | 0.001 |  |  |  |
Monocyte (109/l) | 11.453 | 4.650-28.209 | < 0.001 |  |  |  |
Platelet, 109/L | 0.997 | 0.992–1.003 | 0.308 |  |  |  |
NLR | 1.125 | 1.080–1.171 | < 0.001 |  |  |  |
MLR | 10.320 | 4.705–22.635 | < 0.001 |  |  |  |
Albumin, g/L | 0.818 | 0.749–0.892 | < 0.001 | 0.820 | 0.715–0.940 | 0.004 |
Glucose, mmol/L | 1.146 | 1.070–1.228 | < 0.001 | 1.129 | 1.022–1.246 | 0.017 |
Total cholesterol, mmol/L | 0.768 | 0.586–1.006 | 0.056 |  |  |  |
Triglyceride, mmol/L | 1.018 | 0.795–1.304 | 0.885 |  |  |  |
HDL-c, mmol/L | 4.492 | 1.574–12.815 | 0.005 |  |  |  |
LDL-c, mmol/L | 0.554 | 0.360–0.851 | 0.007 |  |  |  |
eGFR, (ml/min*1.73m2) | 0.988 | 0.979–0.996 | 0.005 | 0.985 | 0.972–0.997 | 0.015 |
Peak CK (*103U/L) | 1.000 | 1.000–1.000 | 0.149 |  |  |  |
Coronary angiography | ||||||
Culprit vessel LADa | 0.778 | 0.422–1.433 | 0.421 |  |  |  |
Culprit vessel LCXa | 0.419 | 0.095–1.846 | 0.250 |  |  |  |
TIMI 3 flow pre-PCI | 1.769 | 0.733–4.267 | 0.204 |  |  |  |
Stent-length | 1.022 | 1.004–1.040 | 0.018 |  |  |  |
SYNTAX score | 1.055 | 1.012-1.100 | 0.012 | Â | Â | Â |
Residual SYNTAX score | 1.054 | 1.005–1.105 | 0.03 |  |  |  |
LA | 1.132 | 1.063–1.206 | < 0.001 |  |  |  |
LVEF | 0.938 | 0.902–0.975 | 0.001 |  |  |  |
Medication during hospitalization | ||||||
 ACEI/ARB | 1.150 | 0.630–2.099 | 0.648 |  |  |  |
 Beta-blockers | 0.403 | 0.219–0.741 | 0.003 |  |  |  |
 MRA | 3.368 | 1.801–6.298 | < 0.001 |  |  |  |
 Statin | 0.881 | 0.334–2.320 | 0.797 |  |  |  |